1 The retractions came only weeks after BioMed Central.

Another can be that it makes life much easier for editors: finding appropriate peer reviewers who are prepared to review in a timely manner can be both hard and frustrating. A third reason could be that journals and publishers are multinational increasingly. In the past, the editor and editorial board of a journal knew both scientific field it covered and the people working in it, but it’s almost impossible to become sufficiently well linked when both editors and submissions come from worldwide.Compared to people who had never smoked, smokers got a three-fold increased threat of a coronary attack. In comparison, moderate and heavy smokers still had a surplus risk of around 22 percent, 20 years after giving up. The team also found that exposure to carbon monoxide smoke increased the risk of coronary attack in both former and non-smokers. The findings claim that individuals with the best levels of exposure to SHS may increase their risk of heart attack by around 45 percent.?.. Abbvie, Galapagos Ink Up To $405M CF Collaboration AbbVie and Galapagos said today they’ll develop and commercialize new oral therapies for cystic fibrosis in a offer that could net Galapagos as much as $405 million. The companies will develop potentiators to increase the activity of the primary mutations in the CF transmembrane regulator proteins, in addition to correctors designed to right defects in CFTR protein expression.